MedTrace Logo

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

NCT06184152 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-08-05

No results posted yet for this study

Summary

The study will be conducted at the following locations:

1. UT Southwestern Medical Center
2. Parkland Health and Hospital System
3. University of Michigan

Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules.

Conditions

Interventions

DIAGNOSTIC_TEST

CEUS imaging

Contrast-enhanced ultrasound (CEUS)

DIAGNOSTIC_TEST

aMRI imaging

contrast enhanced abbreviated MRI (AMRI)

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-28
Primary Completion
2028-11-28
Completion
2028-11-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06184152 on ClinicalTrials.gov